Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclopentolate versus cyclopentolate + tropicamide versus atropine for cycloplegic refraction in dark-irided hyperopic children
NL-OMON30949Active, not recruiting
- Sponsor
- Haaglanden Medical Centre
- Start
- Dec 2007
- Modality
- Classical Binding Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of cyclopentolate, tropicamide and atropine in hypermetropia, sponsored by Haaglanden Medical Centre. Started Dec 2007; status: active, not recruiting.
02
Drugs
cyclopentolatetropicamideatropine
03
Conditions
hypermetropia
Beyond the preview
Go deeper on NL-OMON30949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON30949.